Atlas Trials

Annexon, Inc.

15 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Annexon, Inc.

RecordFirmDate
An Open Label Clinical Study to Evaluate Tanruprubart (Also Commonly Known as ANX005) in Participants With Guillain-Barré Syndrome (FORWARD Study) (NCT07020819)Annexon, Inc.2025-09-12
A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of Vonaprument (Formerly ANX007) in Participants With Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA) (NCT06510816)Annexon, Inc.2024-07-30
A Study of ANX009 in Adult Participants With Lupus Nephritis (NCT05780515)Annexon, Inc.2022-08-09
Dose Study of ANX1502 in Healthy Volunteers (NCT05521269)Annexon, Inc.2022-06-27
Single Ascending Dose Study of ANX105 (NCT05288881)Annexon, Inc.2022-02-28
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ANX005 in Participants With Warm Autoimmune Hemolytic Anemia (wAIHA) (NCT04691570)Annexon, Inc.2021-11-10
A Study Investigating the Efficacy and Safety of Intravitreal Injections of ANX007 in Patients With Geographic Atrophy (NCT04656561)Annexon, Inc.2021-02-26
Study of ANX005 in Adults With Amyotrophic Lateral Sclerosis (ALS) (NCT04569435)Annexon, Inc.2021-01-15
Efficacy and Safety of ANX005 in Subjects With Guillain-Barré Syndrome (NCT04701164)Annexon, Inc.2020-12-17
A Single and Multiple Ascending Dose Study of ANX009 in Normal Healthy Volunteers (NHV) (NCT04535752)Annexon, Inc.2020-10-30
A Clinical Study of ANX005 and IVIG in Subjects With Guillain Barré Syndrome (GBS) (NCT04035135)Annexon, Inc.2020-01-29
Study of ANX007 in Participants With Primary Open-angle Glaucoma (NCT04188015)Annexon, Inc.2018-07-25
Single-dose Study of ANX007 in Participants With Primary Open-angle Glaucoma (NCT03488550)Annexon, Inc.2018-03-23

Track Annexon, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.